| Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation G Fabbri, S Rasi, D Rossi, V Trifonov, H Khiabanian, J Ma, A Grunn, ... Journal of Experimental Medicine 208 (7), 1389-1401, 2011 | 790 | 2011 |
| Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia D Rossi, S Rasi, V Spina, A Bruscaggin, S Monti, C Ciardullo, ... Blood, The Journal of the American Society of Hematology 121 (8), 1403-1412, 2013 | 605 | 2013 |
| Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia D Rossi, S Rasi, G Fabbri, V Spina, M Fangazio, F Forconi, R Marasca, ... Blood, The Journal of the American Society of Hematology 119 (2), 521-529, 2012 | 558 | 2012 |
| The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation D Rossi, V Spina, C Deambrogi, S Rasi, L Laurenti, K Stamatopoulos, ... Blood, The Journal of the American Society of Hematology 117 (12), 3391-3401, 2011 | 423 | 2011 |
| The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells PG Longo, L Laurenti, S Gobessi, S Sica, G Leone, DG Efremov Blood, The Journal of the American Society of Hematology 111 (2), 846-855, 2008 | 375 | 2008 |
| Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells A Petlickovski, L Laurenti, X Li, S Marietti, P Chiusolo, S Sica, G Leone, ... Blood 105 (12), 4820-4827, 2005 | 331 | 2005 |
| ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission F Peyvandi, S Lavoretano, R Palla, HB Feys, K Vanhoorelbeke, ... haematologica 93 (2), 232-239, 2008 | 304 | 2008 |
| The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia D Brusa, S Serra, M Coscia, D Rossi, G D’Arena, L Laurenti, O Jaksic, ... haematologica 98 (6), 953, 2013 | 281 | 2013 |
| The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment V De Stefano, F Sora, E Rossi, P Chiusolo, L Laurenti, L Fianchi, G Zini, ... Journal of Thrombosis and Haemostasis 3 (9), 1985-1992, 2005 | 276 | 2005 |
| Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia D Rossi, L Terzi-di-Bergamo, L De Paoli, M Cerri, G Ghilardi, A Chiarenza, ... Blood, The Journal of the American Society of Hematology 126 (16), 1921-1924, 2015 | 263 | 2015 |
| NOTCH1 mutations in+ 12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis … I Del Giudice, D Rossi, S Chiaretti, M Marinelli, S Tavolaro, S Gabrielli, ... haematologica 97 (3), 437, 2012 | 263 | 2012 |
| COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus L Scarfò, T Chatzikonstantinou, GM Rigolin, G Quaresmini, M Motta, ... Leukemia 34 (9), 2354-2363, 2020 | 260 | 2020 |
| Bruton’s tyrosine kinase (BTK) function is important to the development and expansion of chronic lymphocytic leukemia (CLL) JA Woyach, E Bojnik, AS Ruppert, MR Stefanovski, VM Goettl, ... Blood, The Journal of the American Society of Hematology 123 (8), 1207-1213, 2014 | 258 | 2014 |
| Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome D Rossi, V Spina, M Cerri, S Rasi, C Deambrogi, L De Paoli, L Laurenti, ... Clinical Cancer Research 15 (13), 4415-4422, 2009 | 254 | 2009 |
| Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells S Gobessi, L Laurenti, PG Longo, L Carsetti, V Berno, S Sica, G Leone, ... Leukemia 23 (4), 686-697, 2009 | 249 | 2009 |
| ZAP-70 enhances B-cell–receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells S Gobessi, L Laurenti, PG Longo, S Sica, G Leone, DG Efremov Blood 109 (5), 2032-2039, 2007 | 230 | 2007 |
| Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network V Audrito, T Vaisitti, D Rossi, D Gottardi, G D'Arena, L Laurenti, G Gaidano, ... Cancer research 71 (13), 4473-4483, 2011 | 225 | 2011 |
| Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexate P Chiusolo, G Reddiconto, I Casorelli, L Laurenti, F Sora, L Mele, ... Annals of oncology 13 (12), 1915-1918, 2002 | 210 | 2002 |
| The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease PG Longo, L Laurenti, S Gobessi, A Petlickovski, M Pelosi, P Chiusolo, ... Leukemia 21 (1), 110-120, 2007 | 189 | 2007 |
| High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders A Caivano, I Laurenzana, L De Luca, F La Rocca, V Simeon, S Trino, ... Tumor Biology 36, 9739-9752, 2015 | 186 | 2015 |
